The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, Angelica, Campagnoli, Lucrezia Irene Maria, Fahmideh, Foroogh, Pierella, Elisa, Romeo, Marcello, Ricevuti, Giovanni, Nicoletta, Marchesi, Chirumbolo, Salvatore +1 more·2022·International Journal of Molecular Sciences
DOI 10.3390/ijms232012289

Cites (518)

Items 201–400 of 519

  1. Doxycycline Suppresses Microglial Activation by Inhibiting the P38 MAPK and NF-KB Signaling Pathways
    Santa-Cecília, Flávia V., Socias, Benjamin, Ouidja, Mohand O., Sepulveda-Diaz, Julia E., Acuña, Leonardo, Silva, Rangel L., Michel, Patrick P., Del-Bel, Elaine, Cunha, Thiago M., Raisman-Vozari, Rita · 2016 · Neurotoxicity Research
  2. Biomarkers for Parkinson’s Disease: How Good Are They?
    Tianbai Li, Weidong Le · 2019 · Neuroscience Bulletin
  3. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Clinical and Metabolic Status in Patients with Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Taghizadeh, Mohsen, Tamtaji, Omid Reza, Dadgostar, Ehsan, Daneshvar Kakhaki, Reza, Bahmani, Fereshteh, Abolhassani, Javad, Aarabi, Mohammad Hossein, Kouchaki, Ebrahim, Memarzadeh, Mohammad Reza, Asemi, Zatollah · 2017 · Neurochemistry International
  4. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease
    Hertel, Johannes, Harms, Amy C., Heinken, Almut, Baldini, Federico, Thinnes, Cyrille C., Glaab, Enrico, Vasco, Daniel A., Pietzner, Maik, Stewart, Isobel D., Wareham, Nicholas J. et al. · 2019 · Cell Reports
  5. Effects of the probiotic formulation SLAB51 in <i>in vitro</i> and <i>in vivo</i> Parkinson’s disease models
    Castelli, Vanessa, d’Angelo, Michele, Lombardi, Francesca, Alfonsetti, Margherita, Antonosante, Andrea, Catanesi, Mariano, Benedetti, Elisabetta, Palumbo, Paola, Cifone, Maria Grazia, Giordano, Antonio et al. · 2020 · Aging
  6. Gut microbiota, the immune system, and diet influence the neonatal gut–brain axis
    Michael P. Sherman, Habib Zaghouani, Victoria Niklas · 2014 · Pediatric Research
  7. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics
    Peterson, Christine Tara · 2020 · Journal of Evidence-Based Integrative Medicine
  8. Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity
    Xinxin Yang, Baohua Cheng · 2010 · Journal of Molecular Neuroscience
  9. Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease
    Liao, Jian-Fu, Cheng, Yun-Fang, You, Shu-Ting, Kuo, Wen-Chun, Huang, Chi-Wei, Chiou, Jen-Jie, Hsu, Chih-Chieh, Hsieh-Li, Hsiu-Mei, Wang, Sabrina, Tsai, Ying-Chieh · 2020 · Brain, Behavior, and Immunity
  10. Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
    Yang, Lichuan, Sugama, Shuei, Chirichigno, Jason W., Gregorio, Jason, Lorenzl, Stefan, Shin, Dong H., Browne, Susan E., Shimizu, Yoshinori, Joh, Tong H., Beal, M. Flint et al. · 2003 · Journal of Neuroscience Research
  11. Gastro-Intestinal and Oral Microbiome Signatures Associated with Healthy Aging
    Singh, Harinder, Torralba, Manolito G., Moncera, Kelvin J., DiLello, Lauren, Petrini, Joann, Nelson, Karen E., Pieper, Rembert · 2019 · GeroScience
  12. Parkinson’s Disease and Gut Microbiota
    Hirayama, Masaaki, Ohno, Kinji · 2021 · Annals of Nutrition and Metabolism
  13. Anticholinergic medications in community-dwelling older veterans: Prevalence of anticholinergic symptoms, symptom burden, and adverse drug events
    Jose Ness, Angela B. Hoth, Mitchell J. Barnett, Ronald I. Shorr, Peter J. Kaboli · 2006 · The American Journal of Geriatric Pharmacotherapy
  14. Clinical Potential of Minocycline for Neurodegenerative Disorders
    BLUM, D, CHTARTO, A, TENENBAUM, L, BROTCHI, J, LEVIVIER, M · 2004 · Neurobiology of Disease
  15. Probiotics for Parkinson’s Disease
    Parisa Gazerani · 2019 · International Journal of Molecular Sciences
  16. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders
    Evrensel, Alper, Ceylan, Mehmet Emin · 2016 · Clinical Psychopharmacology and Neuroscience
  17. Beneficial Effects of Flavonoids Against Parkinson's Disease
    Jung, Un Ju, Kim, Sang Ryong · 2018 · Journal of Medicinal Food
  18. The ketone body metabolite β‐hydroxybutyrate induces an antidepression‐associated ramification of microglia via HDACs inhibition‐triggered Akt‐small RhoGTPase activation
    Chao Huang, Peng Wang, Xing Xu, Yaru Zhang, Yu Long Gong, Wenfeng Hu, Minhui Gao, Yue Hui Wu, Yong Ling, Xi Zhao et al. · 2017 · Glia
  19. Neuroprotective potential of ceftriaxone in in vitro models of stroke
    Janusz Lipski, C.K. Wan, Ji‐Zhong Bai, Rongbiao Pi, D. Li, D. Donnelly · 2007 · Neuroscience
  20. Dietary Intake and Depressive Symptoms: A Systematic Review of Observational Studies
    Murakami, Kentaro, Sasaki, Satoshi · 2010 · Molecular Nutrition &amp; Food Research
  21. Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
    Li, Peipei, Killinger, Bryan A., Ensink, Elizabeth, Beddows, Ian, Yilmaz, Ali, Lubben, Noah, Lamp, Jared, Schilthuis, Meghan, Vega, Irving E., Woltjer, Randy et al. · 2021 · Metabolites
  22. Effect of Parkinson’s Disease and Related Medications on the Composition of the Fecal Bacterial Microbiota
    Weis, Severin, Schwiertz, Andreas, Unger, Marcus M., Becker, Anouck, Faßbender, Klaus, Ratering, Stefan, Kohl, Matthias, Schnell, Sylvia, Schäfer, Karl-Herbert, Egert, Markus · 2019 · npj Parkinson s Disease
  23. Diet in Parkinson’s Disease: Critical Role for the Microbiome
    Jackson, Aeja, Forsyth, Christopher B., Shaikh, Maliha, Voigt, Robin M., Engen, Phillip A., Ramirez, Vivian, Keshavarzian, Ali · 2019 · Frontiers in Neurology
  24. Probiotics may have beneficial effects in parkinson’s disease: In vitro evidence
    Magistrelli, Luca, Amoruso, Angela, Mogna, Luca, Graziano, Teresa, Cantello, Roberto, Pane, Marco, Comi, Cristoforo · 2019 · Frontiers in Immunology
  25. Physiology of Mammalian Prevertebral Ganglia
    Joseph H. Szurszewski · 1981 · Annual Review of Physiology
  26. Oral Microbiota and Alzheimer’s Disease: Do All Roads Lead to Rome?
    Sureda, Antoni, Daglia, Maria, Argüelles Castilla, Sandro, Sanadgol, Nima, Fazel Nabavi, Seyed, Khan, Haroon, Belwal, Tarun, Jeandet, Philippe, Marchese, Anna, Pistollato, Francesca et al. · 2020 · Pharmacological Research
  27. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review
    Rebecca J. Solch-Ottaiano, Julia Aigbogun, Andrew G. Voyiadjis, Grant McGee Talkington, Revonda M. Darensbourg, Samantha S. O’Connell, Keith Pickett, Sarah R. Perez, Demetrius M. Maraganore · 2022 · Journal of the Neurological Sciences
  28. The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
    Elaine F. Enright, Cormac G. M. Gahan, Susan A. Joyce, Brendan T. Griffin · 2016 · PubMed Central
  29. Gut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease
    Qian, Yiwei, Yang, Xiaodong, Xu, Shaoqing, Huang, Pei, Li, Binyin, Du, Juanjuan, He, Yixi, Su, Binghua, Xu, Li-Ming, Wang, Liang et al. · 2020 · Brain
  30. Nonmotor gastrointestinal disorders in older patients with Parkinson&amp;rsquo;s disease: is there hope?
    Georgescu, Doina, Ancusa, Oana, Georgescu, Liviu, Ionita, Ioana, Reisz, Daniela · 2016 · Clinical Interventions in Aging
  31. Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans
    Brunetti, Giovanni, Di Rosa, Gabriele, Scuto, Maria, Leri, Manuela, Stefani, Massimo, Schmitz-Linneweber, Christian, Calabrese, Vittorio, Saul, Nadine · 2020 · International Journal of Molecular Sciences
  32. Probiotics synergized with conventional regimen in managing Parkinson’s disease
    Sun, Hairong, Zhao, Feiyan, Liu, Yuanyuan, Ma, Teng, Jin, Hao, Quan, Keyu, Leng, Bing, Zhao, Junwu, Yuan, Xiaoling, Li, Zhenguang et al. · 2022 · npj Parkinson's Disease
  33. MIND Diet Associated with Reduced Incidence and Delayed Progression of Parkinsonism in Old Age
    Puja Agarwal, Y. Wang, Aron S. Buchman, Thomas Monroe Holland, David Alan Bennett, Martha Clare Morris · 2018 · The journal of nutrition health & aging
  34. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders
    Healy-Stoffel, Michelle, Levant, Beth · 2018 · CNS &amp; Neurological Disorders - Drug Targets
  35. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
    Nishiwaki, Hiroshi, Hamaguchi, Tomonari, Ito, Mikako, Ishida, Tomohiro, Maeda, Tetsuya, Kashihara, Kenichi, Tsuboi, Yoshio, Ueyama, Jun, Shimamura, Teppei, Mori, Hiroshi et al. · 2020 · mSystems
  36. Molecular Mechanisms Underlying the Flavonoid-Induced Inhibition of α-Synuclein Fibrillation
    Xiaoyun Meng, Larissa A. Munishkina, Anthony L. Fink, Vladimir Nikolaevich Uversky · 2009 · Biochemistry
  37. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
    Baizabal-Carvallo, José Fidel, Alonso-Juarez, Marlene · 2020 · Neuroscience
  38. The Potential of Minocycline for Neuroprotection in Human Neurologic Disease
    Zemke, Daniel, Majid, Arshad · 2004 · Clinical Neuropharmacology
  39. The Therapeutic Role of Ketogenic Diet in Neurological Disorders
    Diana Pietrzak, Kamila Kasperek, Paweł Rękawek, Iwona Piątkowska‐Chmiel · 2022 · Nutrients
  40. Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
    Segal, Arik, Zlotnik, Yair, Moyal-Atias, Keren, Abuhasira, Ran, Ifergane, Gal · 2021 · Clinical Neurology and Neurosurgery
  41. Clinical and Pharmacokinetic Effects of a Diet Rich in Insoluble Fiber on Parkinson Disease
    R Astarloa, M. A. Mena, V. Sánchez, L. Vega, Justo Garcı́a de Yébenes · 1992 · Clinical Neuropharmacology
  42. Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model
    Márcio Lazzarini, Sabine Martin, Mišo Mitkovski, Rita Raisman‐Vozari, Walter Stühmer, Elaine Del Bel · 2013 · Glia
  43. Repurposing Doxycycline for Synucleinopathies: Remodelling of α-Synuclein Oligomers towards Non-Toxic Parallel Beta-Sheet Structured Species
    González-Lizárraga, Florencia, Socías, Sergio B., Ávila, César L., Torres-Bugeau, Clarisa M., Barbosa, Leandro R. S., Binolfi, Andres, Sepúlveda-Díaz, Julia E., Del-Bel, Elaine, Fernandez, Claudio O., Papy-Garcia, Dulce et al. · 2017 · Scientific Reports
  44. The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
    Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare · 2021 · Cellular and Molecular Neurobiology
  45. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
    Ao‐Ji Xie, Elizabeth Ensink, Peipei Li, Juozas Gordevičius, Lee L. Marshall, Sonia George, John Andrew Pospisilik, Velma T. E. Aho, Madelyn C. Houser, Pedro A. B. Pereira et al. · 2022 · Movement Disorders
  46. MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease
    Avril Metcalfe‐Roach, Adam C. Yu, Ella Golz, Mihai S. Cirstea, Kristen Sundvick, Daniel Kliger, Liam H. Foulger, Melissa Mackenzie, B. Brett Finlay, Silke Appel‐Cresswell · 2021 · Movement Disorders
  47. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
    Nishiwaki, Hiroshi, Ito, Mikako, Hamaguchi, Tomonari, Maeda, Tetsuya, Kashihara, Kenichi, Tsuboi, Yoshio, Ueyama, Jun, Yoshida, Takumi, Hanada, Hiroyuki, Takeuchi, Ichiro et al. · 2022 · npj Parkinson's Disease
  48. Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
    Thomas, M., Le, W. · 2004 · Current Pharmaceutical Design
  49. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease
    Baohua Cheng, Xinxin Yang, Liangxiang An, Bo Gao, Xia Liu, Shuwei Liu · 2009 · Brain Research
  50. The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: A randomized clinical controlled trial
    Paknahad, Zamzam, Sheklabadi, Elham, Derakhshan, Yeganeh, Bagherniya, Mohammad, Chitsaz, Ahmad · 2020 · Complementary Therapies in Medicine
  51. The Role of Microbiome in Brain Development and Neurodegenerative Diseases
    Varsha Nandwana, Nitesh Kumar Nandwana, Yogarupa Das, Mariko Saito, Tanisha Panda, Sasmita Das, Frankis A. Almaguel, Narayan S. Hosmane, Bhaskar C. Das · 2022 · Molecules
  52. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: The evidence for pesticides
    Efthimios Dardiotis, Georgia Xiromerisiou, Christos S. Hadjichristodoulou, Aristidis Michael Tsatsakis, Martin F. Wilks, Georgios M. Hadjigeorgiou · 2013 · Toxicology
  53. Healthspan Enhancement by Olive Polyphenols in C. elegans Wild Type and Parkinson’s Models
    Gabriele Di Rosa, Giovanni Brunetti, Maria Concetta Scuto, Angela Trovato Salinaro, Edward J. Calabrese, Roberto Crea, Christian Schmitz‐Linneweber, Vittorio Calabrese, Nadine Saul · 2020 · International Journal of Molecular Sciences
  54. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
    Pufang Tan, Xiaogang Li, Jun Shen, Qi Feng · 2020 · Frontiers in Pharmacology
  55. Altered Gut Microbiota in Parkinson’s Disease Patients/Healthy Spouses and Its Association with Clinical Features
    Zhang, Fan, Yue, Liya, Fang, Xing, Wang, Gengchao, Li, Cuidan, Sun, Xiaodong, Jia, Xinmiao, Yang, Jingjing, Song, Jinhui, Zhang, Yu et al. · 2020 · Parkinsonism &amp; Related Disorders
  56. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
    Mulak, Agata, Koszewicz, Magdalena, Panek-Jeziorna, Magdalena, Koziorowska-Gawron, Ewa, Budrewicz, Sławomir · 2019 · Frontiers in Neuroscience
  57. Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease
    Kari Erik Murros · 2022 · Cells
  58. Bacterial Lipodipeptide, Lipid 654, Is a Microbiome-Associated Biomarker for Multiple Sclerosis
    Farrokhi, Vahid, Nemati, Reza, Nichols, Frank C, Yao, Xudong, Anstadt, Emily, Fujiwara, Mai, Grady, James, Wakefield, Daniel, Castro, Wanda, Donaldson, James et al. · 2013 · Clinical &amp; Translational Immunology
  59. Increased Urinary Indoxyl Sulfate (Indican): New Insights into Gut Dysbiosis in Parkinson’s Disease
    Cassani, Erica, Barichella, Michela, Cancello, Raffaella, Cavanna, Ferruccio, Iorio, Laura, Cereda, Emanuele, Bolliri, Carlotta, Zampella Maria, Paola, Bianchi, Francesca, Cestaro, Benvenuto et al. · 2015 · Parkinsonism &amp; Related Disorders
  60. Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology
    Bhushan Madke, Swetalina Pradhan, Poonam Kabra, Adarshlata Singh · 2016 · Indian Journal of Dermatology
  61. Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice
    Xin Yang, Chen Diling, Jian Tao Yang, Liu Ting, Hu Guoyan, Liang Hualun, Tang Xiaocui, Guoxiao Lai, Ou Shuai, Zheng Chaoqun et al. · 2018 · Frontiers in Neurology
  62. Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function
    Dipita Bhattacharyya, Ganesh M. Mohite, Janarthanan Krishnamoorthy, Nilanjan Gayen, Surabhi Mehra, Ambuja Navalkar, Samuel A. Kotler, Bhisma Narayan Ratha, Anirban Ghosh, Rakesh Kumar et al. · 2019 · ACS Chemical Neuroscience
  63. Dairy foods and health: an umbrella review of observational studies
    Justyna Godos, Maria Tieri, Francesca Ghelfi, Lucilla Titta, Stefano Marventano, Alessandra Lafranconi, Angelo Gambera, Elena Alonzo, Salvatore Sciacca, Silvio Buscemi et al. · 2019 · International Journal of Food Sciences and Nutrition
  64. Clinical neurophysiology of Parkinson’s disease and parkinsonism
    Robert E. Chen, Alfredo Berardelli, Amitabh Bhattacharya, Matteo Bologna, Kai-Hsiang Stanley Chen, Alfonso A. Fasano, Rick C. G. Helmich, William D. Hutchison, Nitish L. Kamble, Andrea A. Kühn et al. · 2022 · Clinical Neurophysiology Practice
  65. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration
    Chenyin Wang, Chun Yin Lau, Fuqiang Ma, Chaogu Zheng · 2021 · Proceedings of the National Academy of Sciences
  66. Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
    Mariza Bortolanza, Glauce Crivelaro Nascimento, Sergio B. Socías, Diego Ploper, Rosana Nieves Chehín, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2018 · Journal of Neural Transmission
  67. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Ali Keshavarzian, Phillip A. Engen, Salvatore Bonvegna, Roberto Cilia · 2020 · Progress in brain research
  68. Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
    Anderson, George, Seo, Moonsang, Berk, Michael, Carvalho, Andre, Maes, Michael · 2016 · Current Pharmaceutical Design
  69. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease
    Dimitri N. Koutzoumis, Macarena Vergara, José A. Pino, Julia Buddendorff, Habibeh Khoshbouei, Ronald J. Mandel, Gonzalo E. Torres · 2019 · Experimental Neurology
  70. Gut bacterial composition in a mouse model of Parkinson’s disease
    Perez-Pardo, P., Dodiya, H.B., Engen, P.A., Naqib, A., Forsyth, C.B., Green, S.J., Garssen, J., Keshavarzian, A., Kraneveld, A.D. · 2018 · Beneficial Microbes
  71. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
    Barbara Skrzydło-Radomańska, Beata Prozorow-Król, Halina Cichoż‐Lach, Emilia Majsiak, Joanna B. Bierła, Wojciech Kosikowski, Mariusz Szczerbiński, Jesper Gantzel, Božena Cukrowská · 2020 · Nutrients
  72. Effects of Resistant Starch on Symptoms, Fecal Markers and Gut Microbiota in Parkinson’s Disease – The RESISTA-PD Trial
    Becker, Anouck, Schmartz, Georges Pierre, Gröger, Laura, Grammes, Nadja, Galata, Valentina, Philippeit, Hannah, Weiland, Jacqueline, Ludwig, Nicole, Meese, Eckart, Tierling, Sascha et al. · 2021
  73. Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
    Becker, Anouck, Schmartz, Georges Pierre, Gröger, Laura, Grammes, Nadja, Galata, Valentina, Philippeit, Hannah, Weiland, Jacqueline, Ludwig, Nicole, Meese, Eckart, Tierling, Sascha et al. · 2022 · Genomics, Proteomics &amp; Bioinformatics
  74. The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson's Disease: A Randomized, Double-blind, PlaceboControlled Trial.
    Shokoofeh Borzabadi, Shahrbanoo Oryan, Akram Eidi, Esmat Aghadavod, Reza Daneshvar Kakhaki, Omid Reza Tamtaji, Mohsen Taghizadeh, Zatollah Asemi · 2018 · PubMed
  75. Probiotics for Parkinson's disease: Current evidence and future directions
    Ai Huey Tan, Jia Wei Hor, Chun Wie Chong, Shen‐Yang Lim · 2020 · JGH Open
  76. Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
    Loffredo, Lorenzo, Ettorre, Evaristo, Zicari, Anna Maria, Inghilleri, Maurizio, Nocella, Cristina, Perri, Ludovica, Spalice, Alberto, Fossati, Chiara, De Lucia, Maria Caterina, Pigozzi, Fabio et al. · 2020 · Oxidative Medicine and Cellular Longevity
  77. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease
    Dumitrescu, Laura, Marta, Daciana, Dănău, Adela, Lefter, Antonia, Tulbă, Delia, Cozma, Liviu, Manole, Emilia, Gherghiceanu, Mihaela, Ceafalan, Laura Cristina, Popescu, Bogdan Ovidiu · 2021 · Frontiers in Neuroscience
  78. Urate as a Marker of Risk and Progression of Neurodegenerative Disease
    Sabrina Paganoni, Michael A. Schwarzschild · 2016 · Neurotherapeutics
  79. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
    Alain P. Gobert, Giulia Sagrestani, Eve Delmas, Keith T. Wilson, Thomas G. Verriere, Michel C. Dapoigny, Christophe Del’Homme, Annick Bernalier‐Donadille · 2016 · Scientific Reports
  80. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness
    Daryl Ramai · 2018 · Annals of Gastroenterology
  81. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
    Li, Fang, Wang, Peng, Chen, Zhu, Sui, Xiafei, Xie, Xinyu, Zhang, Jinbiao · 2019 · Neuroscience Letters
  82. The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge
    van IJzendoorn, Sven C. D., Derkinderen, Pascal · 2019 · Journal of Parkinson’s Disease
  83. Mediterranean Dietary Pattern at Middle Age and Risk of Parkinson's Disease: A Swedish Cohort Study
    Weiyao Yin, Marie Löf, Nancy L. Pedersen, Sven Sandin, Fang Fang · 2020 · Movement Disorders
  84. Prognostic significance of the onset mode in parkinsonism
    Ali H. Rajput, Rajesh Pahwa, Punam Pahwa, Alex H. Rajput · 1993 · Neurology
  85. Diet pattern and prodromal features of Parkinson disease
    Samantha A. Molsberry, Kjetil Bjørnevik, Katherine C. Hughes, Brian C. Healy, Michael A. Schwarzschild, Alberto Ascherio · 2020 · Neurology
  86. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
    Mihaila, Dragos, Donegan, Jordan, Barns, Sarah, LaRocca, Daria, Du, Qian, Zheng, Danny, Vidal, Michael, Neville, Christopher, Uhlig, Richard, Middleton, Frank A. · 2019 · PLOS ONE
  87. The Therapeutic Role of Minocycline in Parkinson’s Disease
    Cankaya, Seyda, Cankaya, Baris, Kilic, Ulkan, Kilic, Ertugrul, Yulug, Burak · 2019 · Drugs in Context
  88. Light-Sensitive Lactococcus lactis for Microbe–Gut–Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System
    Huizhuo Pan, Tao Sun, Meihui Cui, Ning Ma, Chun Yang, Jing Liu, Gaoju Pang, Baona Liu, Lianyue Li, Xinyu Zhang et al. · 2022 · ACS Nano
  89. Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model
    Chen-Meng Qiao, Mengfei Sun, Xue-Bing Jia, Li Yang, Bo-Ping Zhang, Liping Zhao, Yun Wei Shi, Zhi-Lan Zhou, Yingli Zhu, Chun Cui et al. · 2020 · Neurochemical Research
  90. Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
    Carolina Pellegrini, Vanessa D’Antongiovanni, Fabiana Miraglia, Lucia Rota, Laura Benvenuti, Clelia Di Salvo, Giovanna Testa, Simona Capsoni, Gianfranca Carta, Luca Antonioli et al. · 2022 · npj Parkinson s Disease
  91. Oral Dysbiosis and Inflammation in Parkinson’s Disease
    Vanessa Fleury, Alkisti Zekeridou, Vladimir Lazarević, Nadia Gaïa, Catherine Giannopoulou, Laurence Genton, José Cancela, Myriam Girard, Rachel Goldstein, Julien François Bally et al. · 2021 · Journal of Parkinson s Disease
  92. Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice
    Chaonan Sun, Ling Chen, Zhu Shen · 2019 · Saudi Pharmaceutical Journal
  93. Effects of oral administration of rotenone on gastrointestinal functions in mice
    Maddalena Tasselli, Tanguy Chaumette, Sébastien Paillusson, Yann Monnet, Aude Lafoux, Corinne Huchet, Philippe Aubert, Stéphane Hunot, Pascal Derkinderen, Michel Neunlist · 2013 · Neurogastroenterology & Motility
  94. A new face for old antibiotics: tetracyclines in treatment of amyloidoses.
    T. Stoilova, L. Colombo, G. Forloni, F. Tagliavini, M. Salmona · 2013 · Journal of Medicinal Chemistry
  95. Neuroprotective Effect of Omega-3 Polyunsaturated Fatty Acids in the 6-OHDA Model of Parkinson’s Disease Is Mediated by a Reduction of Inducible Nitric Oxide Synthase
    Mori, Marco Aurélio, Delattre, Ana Marcia, Carabelli, Bruno, Pudell, Claudia, Bortolanza, Mariza, Staziaki, Pedro Vinícius, Visentainer, Jesuí Vergilio, Montanher, Paula Fernandes, Del Bel, Elaine A., Ferraz, Anete Curte · 2018 · Nutritional Neuroscience
  96. Alterations of gut microbiota and metabolome with Parkinson's disease
    Zhenzhen Yan, Fan Yang, Jingwei Cao, Wencai Ding, Shi Yan, Wanying Shi, Shirong Wen, Lifen Yao · 2021 · Microbial Pathogenesis
  97. Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
    Xiang, Shuai, Ji, Jin-Long, Li, Sha, Cao, Xi-Peng, Xu, Wei, Tan, Lan, Tan, Chen-Chen · 2022 · Frontiers in Aging Neuroscience
  98. Intestinal Permeability and Orocaecal Transit Time in Elderly Patients with Parkinson’s Disease
    Davies, K N, King, D, Billington, D, Barrett, J A · 1996 · Postgraduate Medical Journal
  99. Antibiotic Exposure and Risk of Parkinson's Disease in Finland: A Nationwide Case‐Control Study
    Mertsalmi, Tuomas H., Pekkonen, Eero, Scheperjans, Filip · 2020 · Movement Disorders
  100. Akkermansia muciniphila induces mitochondrial calcium overload and α -synuclein aggregation in an enteroendocrine cell line
    Dionísio Pedro Amorim Neto, Beatriz Pelegrini Bosque, João Vitor Pereira de Godoy, Paulla Vieira Rodrigues, Dario Donoso Meneses, Katiane Tostes, C.C.C. Tonoli, Hernandes F. Carvalho, Christian Enrique González-Billault, Matheus de Castro Fonseca · 2022 · iScience
  101. Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice
    Feng, Yu-Kun, Wu, Qiong-Li, Peng, Yan-Wen, Liang, Feng-Yin, You, Hua-Jing, Feng, Yi-Wei, Li, Ge, Li, Xue-Jiao, Liu, Shu-Hua, Li, Yong-Chao et al. · 2020 · Journal of Neuroinflammation
  102. Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model
    Chotibut, Tanya, Davis, Richard W., Arnold, Jennifer C., Frenchek, Zachary, Gurwara, Shawn, Bondada, Vimala, Geddes, James W., Salvatore, Michael F. · 2014 · Molecular Neurobiology
  103. Doxycycline Is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
    Cho, Yuri, Son, Hyo Jin, Kim, Eun-Mee, Choi, Ji Hyun, Kim, Sung Tae, Ji, In Jung, Choi, Dong Hee, Joh, Tong H., Kim, Yoon Seong, Hwang, Onyou · 2009 · Neurotoxicity Research
  104. Bioconversion of l-tyrosine to l-DOPA by a novel bacterium Bacillus sp. JPJ
    Shripad N. Surwase, Jyoti Prafulla Jadhav · 2010 · Amino Acids
  105. Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota
    Zhou, Xiaoting, Lu, Jiachen, Wei, Kehong, Wei, Jing, Tian, Puyuan, Yue, Mengyun, Wang, Yun, Hong, Daojun, Li, Fangjun, Wang, Bo et al. · 2021 · Oxidative Medicine and Cellular Longevity
  106. Oral and Gut Dysbiosis Leads to Functional Alterations in Parkinson’s Disease
    Jo, Sungyang, Kang, Woorim, Hwang, Yun Su, Lee, Seung Hyun, Park, Kye Won, Kim, Mi Sun, Lee, Hyunna, Yoon, Hyung Jeong, Park, Yoo Kyoung, Chalita, Mauricio et al. · 2022 · npj Parkinson s Disease
  107. Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
    Thaisa M. Cantu-Jungles, Heather Elizabeth Rasmussen, Bruce R. Hamaker · 2019 · Frontiers in Neurology
  108. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson’s disease
    Yi Xu, Mengmeng Xie, Jinsong Xue, Ling Xiang, Yali Li, Jie Xiao, Guiran Xiao, Hui‐Li Wang · 2020 · The FASEB Journal
  109. Clinical advantages of COMT inhibition with entacapone ? a review
    A. Gordin, Seppo Kaakkola, Heikki Ter�v�inen · 2004 · Journal of Neural Transmission
  110. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model
    Ruan, Zhengzheng, Zhang, Dongdong, Huang, Ruixue, Sun, Wei, Hou, Liyan, Zhao, Jie, Wang, Qingshan · 2022 · International Journal of Molecular Sciences
  111. Parkinson's Disease Is Associated with Impaired <scp>Gut–Blood</scp> Barrier for <scp>Short‐Chain</scp> Fatty Acids
    Yang, Xiaodong, Ai, Penghui, He, Xiaoqin, Mo, Chengjun, Zhang, Yi, Xu, Shaoqing, Lai, Yiqiu, Qian, Yiwei, Xiao, Qin · 2022 · Movement Disorders
  112. Doxycycline Inhibits α-Synuclein-Associated Pathologies in Vitro and in Vivo
    Dominguez-Meijide, Antonio, Parrales, Valeria, Vasili, Eftychia, González-Lizárraga, Florencia, König, Annekatrin, Lázaro, Diana F., Lannuzel, Annie, Haik, Stéphane, Del Bel, Elaine, Chehín, Rosana et al. · 2021 · Neurobiology of Disease
  113. Role of probiotics and prebiotics in mitigation of different diseases
    Sabeena Manzoor, Shoib Mohmad Wani, Sajad Ahmad Mir, Danish Rizwan · 2022 · Nutrition
  114. Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?
    Salat-Foix, D., Tran, K., Ranawaya, R., Meddings, J., Suchowersky, O. · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  115. Antibiotic-Induced Microbiome Depletion Protects against MPTP-Induced Dopaminergic Neurotoxicity in the Brain
    Pu, Yaoyu, Chang, Lijia, Qu, Youge, Wang, Siming, Zhang, Kai, Hashimoto, Kenji · 2019 · Aging
  116. The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study
    Chin‐Song Lu, Hsiu‐Chen Chang, Yi-Hsin Weng, Chiung-Chu Chen, Yi-Shan Kuo, Ying-Chieh Tsai · 2021 · Frontiers in Nutrition
  117. Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson’s Disease Rats
    Tsao, Shu-Ping, Nurrahma, Bira Arumndari, Kumar, Ravi, Wu, Chieh-Hsi, Yeh, Tu-Hsueh, Chiu, Ching-Chi, Lee, Yen-Peng, Liao, Yi-Chi, Huang, Cheng-Hsieh, Yeh, Yao-Tsung et al. · 2021 · Antioxidants
  118. Ceftriaxone Ameliorates Motor Deficits and Protects Dopaminergic Neurons in 6-Hydroxydopamine-Lesioned Rats
    Leung, T. C. H., Lui, C. N. P., Chen, L. W., Yung, W. H., Chan, Y. S., Yung, K. K. L. · 2012 · ACS Chemical Neuroscience
  119. The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD
    Rane, Pallavi, Shields, Jessica, Heffernan, Meghan, Guo, Yin, Akbarian, Schahram, King, Jean A. · 2012 · Neuropharmacology
  120. Dietary habits in Parkinson's disease: Adherence to Mediterranean diet
    Erica Cassani, Michela Barichella, Valentina Ferri, Giovanna Pinelli, Laura Iorio, Carlotta Bolliri, Serena Caronni, S.A. Faierman, Antonia Mottolese, Chiara Pusani et al. · 2017 · Parkinsonism & Related Disorders
  121. Prebiotic Lactulose Ameliorates the Cognitive Deficit in Alzheimer’s Disease Mouse Model through Macroautophagy and Chaperone-Mediated Autophagy Pathways
    Yan-Suan Lee, Dar‐Ming Lai, Hei-Jen Huang, Guey‐Jen Lee‐Chen, Ching-Hwa Chang, Hsiu Mei Hsieh‐Li, Guan-Chiun Lee · 2021 · Journal of Agricultural and Food Chemistry
  122. Polymannuronic Acid Prebiotic plus Lacticaseibacillus Rhamnosus GG Probiotic as a Novel Synbiotic Promoted Their Separate Neuroprotection against Parkinson’s Disease
    Liu, Xin, Du, Zhong Rui, Wang, Xiong, Sun, Xiang Rong, Zhao, Qing, Zhao, Fang, Wong, Wing Tak, Wong, Ka Hing, Dong, Xiao-Li · 2022 · Food Research International
  123. GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib
    Li, Junyu, Ma, Shanshan, Chen, Jingnan, Hu, Kunhua, Li, Yongyi, Zhang, Zeyu, Su, Zixiang, Woodgett, James R., Li, Mingtao, Huang, Qiaoying · 2020 · Frontiers in Molecular Neuroscience
  124. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model
    Daiana Pérez Visñuk, Graciela Savoy de Giori, Jean Guy LeBlanc, Alejandra de Moreno de LeBlanc · 2020 · Nutrition
  125. Promising effects of neurorestorative diets on motor, cognitive, and gastrointestinal dysfunction after symptom development in a mouse model of Parkinson's disease
    Perez-Pardo, Paula, de Jong, Esther M., Broersen, Laus M., van Wijk, Nick, Attali, Amos, Garssen, Johan, Kraneveld, Aletta D. · 2017 · Frontiers in Aging Neuroscience
  126. Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
    Claudia Balducci, Gianluigi Forloni · 2019 · Frontiers in Pharmacology
  127. Potential Treatment of Parkinson’s Disease with Omega-3 Polyunsaturated Fatty Acids
    Li, Peng, Song, Cai · 2022 · Nutritional Neuroscience
  128. Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide as a Biomarker in Early Parkinson’s Disease
    Chung, Seok Jong, Rim, John Hoon, Ji, Dajeong, Lee, Sangwon, Yoo, Han Soo, Jung, Jin Ho, Baik, KyoungWon, Choi, Yonghoon, Ye, Byoung Seok, Sohn, Young H. et al. · 2021 · Nutrition
  129. Geographic Differences in Gut Microbiota Composition Impact Susceptibility to Enteric Infection
    Porras, Ana Maria, Shi, Qiaojuan, Zhou, Hao, Callahan, Rowan, Montenegro-Bethancourt, Gabriella, Solomons, Noel, Brito, Ilana Lauren · 2021 · Cell Reports
  130. Fatty Acids and Homocysteine Levels in Patients with Recurrent Depression: An Explorative Pilot Study
    Assies, J, Lok, A, Bockting, C.L, Weverling, G.J, Lieverse, R, Visser, I, Abeling, N.G.G.M, Duran, M, Schene, A.H · 2004 · Prostaglandins Leukotrienes and Essential Fatty Acids
  131. Induction of Neuronal Differentiation of Murine N2a Cells by Two Polyphenols Present in the Mediterranean Diet Mimicking Neurotrophins Activities: Resveratrol and Apigenin
    Amira Namsi, Thomas Nury, Haithem Hamdouni, Aline Yammine, Anne Véjux, Dominique Fasseur, Norbert Latruffe, Olfa Masmoudi‐Kouki, Gérard Lizard · 2018 · Diseases
  132. Seafood Consumption, Omega-3 Fatty Acids Intake, and Life-Time Prevalence of Depression in the PREDIMED-Plus Trial
    Sánchez-Villegas, Almudena, Álvarez-Pérez, Jacqueline, Toledo, Estefanía, Salas-Salvadó, Jordi, Ortega-Azorín, Carolina, Zomeño, Maria Dolores, Vioque, Jesús, Martínez, Jose Alfredo, Romaguera, Dora, Pérez-López, Jessica et al. · 2018 · Nutrients
  133. Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1
    Fang, Xin, Tian, Puyuan, Zhao, Xiaoxiao, Jiang, Chunling, Chen, Tingtao · 2019 · Journal of Neurochemistry
  134. Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
    Yimer, Ebrahim M., Hishe, Hailemichael Zeru, Tuem, Kald Beshir · 2019 · Frontiers in Neuroscience
  135. Viruses, parkinsonism and Parkinson’s disease: the past, present and future
    Valentina Leta, Daniele Urso, Lucia Batzu, Yue Hui Lau, Donna Mathew, Iro Boura, Vanessa Raeder, Cristian Falup‐Pecurariu, Daniel J. van Wamelen, К. Ray Chaudhuri · 2022 · Journal of Neural Transmission
  136. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease
    Jacob D. Jones, Elizabeth Rahmani, Erik Garcia, Jonathan P. Jacobs · 2020 · Parkinsonism & Related Disorders
  137. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
    Fang, Xin, Zhou, Xiaoting, Miao, Yuqing, Han, Yiwen, Wei, Jing, Chen, Tingtao · 2020 · AMB Express
  138. Minocycline Blocks 6-Hydroxydopamine-Induced Neurotoxicity and Free Radical Production in Rat Cerebellar Granule Neurons
    Lin, Suizhen, Wei, Xing, Xu, Yong, Yan, Chong, Dodel, Richard, Zhang, Yuqin, Liu, Junyi, Klaunig, James E., Farlow, Martin, Du, Yansheng · 2003 · Life Sciences
  139. Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro
    Ruzza, Paolo, Siligardi, Giuliano, Hussain, Rohanah, Marchiani, Anna, Islami, Mehmet, Bubacco, Luigi, Delogu, Giovanna, Fabbri, Davide, Dettori, Maria A., Sechi, Mario et al. · 2014 · ACS Chemical Neuroscience
  140. Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease
    Smaga, Irena, Fierro, Daniel, Mesa, Javier, Filip, Malgorzata, Knackstedt, Lori A · 2020 · Neuroscience &amp; Biobehavioral Reviews
  141. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study
    Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri · 2020 · Journal of Immunoassay and Immunochemistry
  142. New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
    Lorente-Picón, Marina, Laguna, Ariadna · 2021 · Biomolecules
  143. Techniques of Functional and Motility Test: How to Perform and Interpret Intestinal Permeability
    Asha Mishra, Govind Kumar Makharia · 2012 · Journal of Neurogastroenterology and Motility
  144. Neuroprotective and Neuro-Restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson’s Disease
    Cronin, Aileen, Grealy, Maura · 2017 · Neuroscience
  145. Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death
    Huajun Jin, Arthi Kanthasamy, Dilshan S. Harischandra, Naveen Chandra Kondru, Anamitra Ghosh, Nikhil Panicker, Vellareddy Anantharam, Ajay Rana, Anumantha G. Kanthasamy · 2014 · Journal of Biological Chemistry
  146. Adolescence and Aging: Impact of Adolescence Inflammatory Stress and Microbiota Alterations on Brain Development, Aging, and Neurodegeneration
    Nour Yahfoufi, Chantal Matar, Nafissa Ismail · 2020 · The Journals of Gerontology Series A
  147. Targeting the Microbiota in Pharmacology of Psychiatric Disorders
    Pascale, Alessia, Marchesi, Nicoletta, Govoni, Stefano, Barbieri, Annalisa · 2020 · Pharmacological Research
  148. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients
    Wu, Gang, Jiang, Zhengli, Pu, Yaling, Chen, Shiyong, Wang, Tingling, Wang, Yajing, Xu, Xiaoping, Wang, Shanshan, Jin, Minya, Yao, Yangyang et al. · 2022 · BMC Neurology
  149. Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
    Zhong, Zhe, Chen, Weijie, Gao, Huan, Che, Ningning, Xu, Min, Yang, Lanqing, Zhang, Yingfang, Ye, Min · 2021 · Neurochemical Research
  150. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy
    Richard G. Gray, Smitaa Patel, Natalie J. Ives, Caroline Rick, Rebecca L. Woolley, Sharon Muzerengi, Alastair McIntosh Gray, Crispin Jenkinson, Emma McIntosh, Keith Wheatley et al. · 2021 · JAMA Neurology
  151. Effects of Ceftriaxone on the Behavioral and Neuronal Changes in an MPTP-Induced Parkinson’s Disease Rat Model
    Ho, Shih-Chun, Hsu, Chih-Chuan, Pawlak, Cornelius Rainer, Tikhonova, Maria A., Lai, Te-Jen, Amstislavskaya, Tamara G., Ho, Ying-Jui · 2014 · Behavioural Brain Research
  152. Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
    Anubhuti Dixit, Garima Srivastava, Divya Verma, Manisha Mishra, Pradhyumna Kumar Singh, Om Prakash, Mahendra Pratap Singh · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  153. Ceftriaxone Prevents and Reverses Behavioral and Neuronal Deficits in an MPTP-Induced Animal Model of Parkinson’s Disease Dementia
    Hsu, Chao-Yu, Hung, Ching-Sui, Chang, Hung-Ming, Liao, Wen-Chieh, Ho, Shih-Chun, Ho, Ying-Jui · 2015 · Neuropharmacology
  154. Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study
    Rusch, Carley, Beke, Matthew, Tucciarone, Lily, Nieves, Carmelo, Ukhanova, Maria, Tagliamonte, Massimiliano S., Mai, Volker, Suh, Joon Hyuk, Wang, Yu, Chiu, Shannon et al. · 2021 · Frontiers in Neurology
  155. Minocycline and Other Tetracycline Derivatives: A Neuroprotective Strategy in Parkinson’s Disease and Huntington’s Disease
    Thomas, Madhavi, Le, Wei Dong, Jankovic, Joseph · 2003 · Clinical Neuropharmacology
  156. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats
    Bisht, Rohit, Kaur, Baninder, Gupta, Hitu, Prakash, Atish · 2014 · NeuroToxicology
  157. Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
    Acuña, Leonardo, Hamadat, Sabah, Corbalán, Natalia S., González-Lizárraga, Florencia, dos-Santos-Pereira, Mauricio, Rocca, Jérémy, Sepúlveda Díaz, Julia, Del-Bel, Elaine, Papy-García, Dulce, Chehín, Rosana N. et al. · 2019 · Cells
  158. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications
    Angelica Varesi, Undine-Sophie Deumer, S. Vijay Ananth, Giovanni Ricevuti · 2021 · Journal of Clinical Medicine
  159. The Influence of Polyphenol Compounds on Human Gastrointestinal Tract Microbiota
    Michał Wiciński, Jakub Gębalski, Ewelina Mazurek, Marta Podhorecka, Maciej Śniegocki, Paweł Szychta, Ewelina Sawicka, Bartosz Malinowski · 2020 · Nutrients
  160. Omega 3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
    Rossella Avallone, Giovanni Vitale, Marco Bertolotti · 2019 · Preprints.org
  161. Antibiotics and the Nervous System—Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?
    Hurkacz, Magdalena, Dobrek, Lukasz, Wiela-Hojeńska, Anna · 2021 · Molecules
  162. Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
    Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo · 2022 · Nutrients
  163. Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions
    Francisco-José Fernández-Gómez, María Francisca Galindo, María Gómez-Lázaro, C. González-García, Valentı́n Ceña, Norberto Aguirre, Joaquı́n Jordán · 2005 · Neuroscience
  164. The efficacy of the ketogenic diet on motor functions in Parkinson's disease: A rat model.
    Sheida Shaafi, Safa Najmi, Hamed Aliasgharpour, Javad Mahmoudi, Saeed Sadigh-Etemad, Mehdi Farhoudi, Negar Baniasadi · 2016 · Europe PMC (PubMed Central)
  165. Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease
    Yuqing Yuan, Yali Wang, Baoshi Yuan, Xin Yuan, Xiao‐Ou Hou, Jin‐Song Bian, Chun‐Feng Liu, Li‐Fang Hu · 2017 · Brain Behavior and Immunity
  166. The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
    Lubomski, Michal, Xu, Xiangnan, Holmes, Andrew J., Muller, Samuel, Yang, Jean Y. H., Davis, Ryan L., Sue, Carolyn M. · 2022 · Frontiers in Aging Neuroscience
  167. Behavioral and Morphological Effects of Minocycline in the 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    Quintero, Elias Matthew, Willis, Lauren, Singleton, Rachel, Harris, Naida, Huang, Peng, Bhat, Narayan, Granholm, Ann-Charlotte · 2006 · Brain Research
  168. Personalized Nutrition Through The Gut Microbiota: Current Insights And Future Perspectives
    Doris Vandeputte · 2020 · Nutrition Reviews
  169. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics
    Huan Yang, Yuqing Liu, Rui Cai, Ying Li, Bing Gu · 2021 · Annals of Palliative Medicine
  170. Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
    Jonathan Plassais, Guillaume Gbikpi‐Benissan, Marine Figarol, Filip Scheperjans, Guy Gorochov, Pascal Derkinderen, Alessandra Cervino · 2021 · Brain Communications
  171. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease
    Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, Pieter Van den Abbeele, Arnout Bruggeman, Jawal Said, Barry Smith, Lynne Ann Barker, Caroline Jordan, Valentina Leta et al. · 2021 · International Journal of Pharmaceutics X
  172. Abnormal Lipopolysaccharide Binding Protein as Marker of Gastrointestinal Inflammation in Parkinson Disease
    Pal, Gian D., Shaikh, Maliha, Forsyth, Christopher B., Ouyang, Bichun, Keshavarzian, Ali, Shannon, Kathleen M. · 2015 · Frontiers in Neuroscience
  173. A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
    Guadalupe Vidal-Martínez, Brandon Chin, Cynthia Camarillo, Gloria V. Herrera, Barbara Carolyn Yang, Irene Sarosiek, Ruth G. Perez · 2019 · Journal of Parkinson s Disease
  174. Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
    Sebastiaan P. van Kessel, Hiltje R. de Jong, Simon L. Winkel, Sander Sebastiaan van Leeuwen, Sieger A. Nelemans, Hjalmar P. Permentier, Ali Keshavarzian, Sahar El Aidy · 2020 · BMC Biology
  175. Probiotics and the Treatment of Parkinson's Disease: An Update
    Mirzaei, Hamed, Sedighi, Saman, Kouchaki, Ebrahim, Barati, Erfaneh, Dadgostar, Ehsan, Aschner, Michael, Tamtaji, Omid Reza · 2022 · Cellular and Molecular Neurobiology
  176. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson’s Disease
    Szu‐Ju Chen, Chieh‐Chang Chen, Hsin-Yu Liao, Yu‐Wei Wu, Jyh‐Ming Liou, Ming‐Shiang Wu, Ching‐Hua Kuo, Chin‐Hsien Lin · 2022 · Journal of Parkinson s Disease
  177. Ceftriaxone reduces <scp>L</scp> ‐dopa–induced dyskinesia severity in 6‐hydroxydopamine parkinson's disease model
    Chotibut, Tanya, Meadows, Samantha, Kasanga, Ella A., McInnis, Tamara, Cantu, Mark A., Bishop, Christopher, Salvatore, Michael F. · 2017 · Movement Disorders
  178. Longitudinal study of the bacterial and fungal microbiota in the human sinuses reveals seasonal and annual changes in diversity
    Brett Wagner Mackenzie, Kevin Chang, Melissa Zoing, Ravi Jain, Michael Hoggard, Kristi Biswas, Richard George Douglas, Michael W. Taylor · 2019 · Scientific Reports
  179. Gut, oral and nasal microbiota and Parkinson’s disease
    Liang Shen · 2020 · Microbial Cell Factories
  180. Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson’s Disease
    Caroline Xie, Asheeta A. Prasad · 2020 · Microorganisms
  181. Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
    Sara Gerhardt, M. Hasan Mohajeri · 2018 · Preprints.org
  182. The Oral Microbiome and Inflammation in Mild Cognitive Impairment
    Yang, Irene, Arthur, Robert Adam, Zhao, Liping, Clark, Jasmine, Hu, Yijuan, Corwin, Elizabeth J., Lah, James · 2021 · Experimental Gerontology
  183. Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism
    Bira Arumndari Nurrahma, Shu‐Ping Tsao, Chieh‐Hsi Wu, Tu‐Hsueh Yeh, Pei-Shan Hsieh, Binar Panunggal, Hui-Yu Huang · 2021 · Frontiers in Aging Neuroscience
  184. Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an α-Synuclein multimer
    Jie Xu, Chuangzhen Wei, Changqing Xu, M. Catherine Bennett, Guohua Zhang, Fangcheng Li, Enxiang Tao · 2007 · Brain Research
  185. Omega-3 Deficiency and Neurodegeneration in the Substantia Nigra: Involvement of Increased Nitric Oxide Production and Reduced BDNF Expression
    Cardoso, Henriqueta Dias, Santos Junior, Eraldo Fonseca dos, de Santana, David Filipe, Gonçalves-Pimentel, Catarina, Angelim, Monara Kaélle, Isaac, Alinny R., Lagranha, Cláudia Jacques, Guedes, Rubem Carlos Araújo, Beltrão, Eduardo Isidoro, Morya, Edgar et al. · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
  186. Rifampicin Inhibits Rotenone-Induced Microglial Inflammation via Enhancement of Autophagy
    Liang, Yanran, Zhou, Tianen, Chen, Ying, Lin, Danyu, Jing, Xiuna, Peng, Sudan, Zheng, Dezhi, Zeng, Zhifen, Lei, Ming, Wu, Xia et al. · 2017 · NeuroToxicology
  187. Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3β/CREB Signaling Pathway
    Wu, Xia, Liang, Yanran, Jing, Xiuna, Lin, Danyu, Chen, Ying, Zhou, Tianen, Peng, Sudan, Zheng, Dezhi, Zeng, Zhifen, Lei, Ming et al. · 2018 · Neurochemical Research
  188. The effects of Mediterranean diet on severity of disease and serum Total Antioxidant Capacity (TAC) in patients with Parkinson’s disease: a single center, randomized controlled trial
    Zamzam Paknahad, Elham Sheklabadi, Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh · 2020 · Nutritional Neuroscience
  189. The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer’s Disease
    Mihai S. Cirstea, Daniel Kliger, Abbey D. MacLellan, Adam C. Yu, Jenna Langlois, Mannie Fan, Seti Boroomand, Faezeh Kharazyan, Robin G.Y. Hsiung, Brian A. MacVicar et al. · 2022 · Journal of Alzheimer s Disease
  190. Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson’s disease in rats
    Kaur, Baninder, Prakash, Atish · 2017 · Pathophysiology
  191. Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
    Romo-Vaquero, María, Fernández-Villalba, Emiliano, Gil-Martinez, Ana-Luisa, Cuenca-Bermejo, Lorena, Espín, Juan Carlos, Herrero, María Trinidad, Selma, María Victoria · 2022 · Food &amp; Function
  192. Nigrostriatal Dopaminergic Neurodegeneration in the<i>Weaver</i>Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration
    Peng, Jun, Xie, Lin, Stevenson, Fang Feng, Melov, Simon, Di Monte, Donato A., Andersen, Julie K. · 2006 · The Journal of Neuroscience
  193. Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
    Ruwani Wijeyekoon, Sarah F. Moore, Krista Farrell, David P. Breen, Roger A. Barker, Caroline H. Williams‐Gray · 2020 · Movement Disorders
  194. Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
    Arrona Cardoza, Pablo, Spillane, Micheil B, Morales Marroquin, Elisa · 2022 · Nutrition Reviews
  195. Potential therapeutic effects of polyphenols in Parkinson’s disease: in vivo and in vitro pre-clinical studies
    Claudio Giuliano, Silvia Cerri, Fabio Blandini · 2020 · Neural Regeneration Research
  196. Efficacy of Probiotics in Multiple Sclerosis: A Systematic Review of Preclinical Trials and Meta-Analysis of Randomized Controlled Trials
    Jiang, Jinchi, Chu, Chuanqi, Wu, Caie, Wang, Chen, Zhang, Chengcheng, Li, Tiantian, Zhai, Qixiao, Yu, Leilei, Tian, Fengwei, Chen, Wei · 2021 · Food &amp; Function
  197. Oral, Nasal, and Gut Microbiota in Parkinson’s Disease
    Li, Zhuo, Lu, Gang, Luo, Enli, Wu, Bin, Li, Zhe, Guo, Jianwen, Xia, Zhangyong, Zheng, Chunye, Su, Qiaozhen, Zeng, Yan et al. · 2022 · Neuroscience
  198. RIFAMPICIN: An antibiotic with brain protective function
    Burak Yuluğ, Lütfü Hanoğlu, Ertuğrul Kılıç, Wolf Rüdiger Schabitz · 2014 · Brain Research Bulletin
  199. Can Gut Microbiota Be a Good Predictor for Parkinson’s Disease? A Machine Learning Approach
    Daniele Pietrucci, Adelaide Teofani, Valeria Unida, Rocco Cerroni, Silvia Biocca, Alessandro Stefani, Alessandro Desideri · 2020 · Brain Sciences
  200. Does Gut Microbiota Influence the Course of Parkinson’s Disease? A 3-Year Prospective Exploratory Study in de novo Patients
    Roberto Cilia, Marco Piatti, Emanuele Cereda, Carlotta Bolliri, Serena Caronni, Valentina Ferri, Erica Cassani, Salvatore Bonvegna, Carlo Ferrarese, Anna Zecchinelli et al. · 2020 · Journal of Parkinson s Disease